FDA applicant
Insulet Corporation
FDA records 25 decisions for Insulet Corporation (Acton, MA) from 2003 to 2026: 25 510(k) clearances. Most are in product codes LZG (Pump, Infusion, Insulin) and QJI (Interoperable Automated Glycemic Controller). Since 2016 its 510(k)s took a median of 103 days from receipt to decision, against 140 for FDA’s reviews in the same codes and years. Its devices cite 24 predicates, 20 of them its own earlier devices. 23 recalls are linked to its devices, 10 Class I.
FDA’s records also spell it “Insulet Corp.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Insulet Corporation’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
4in 2026
Class I Class II/III not classified
Planning a device like Insulet Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report